Cathay Biotech: Announcement of the resolution of the 23rd meeting of the second board of supervisors
DATE:  Dec 31 2024

Stock code: 688065 Stock abbreviation: Cathay Biotech Announcement No.: 2024-071

Shanghai Cathay Biotechnology Co., Ltd

Announcement of the resolution of the 23rd meeting of the second board of supervisors

The Board of Supervisors and all supervisors of the Company guarantee that there are no false records, misleading statements or material omissions in the content of this announcement, and assume legal responsibility for the authenticity, accuracy and completeness of its content in accordance with the law.

1. The convening of the meeting of the board of supervisors

Shanghai Cathay Biotechnology Co., Ltd. (hereinafter referred to as the "Company") issued a report on December 19, 2024

All Audit & Supervisory Board members will send out regular meeting notices by email and hold a communication meeting at 15:00 on December 30, 2024

The 23rd meeting of the second board of supervisors was held. The meeting was presided over by Zhang Guohua, chairman of the board of supervisors, and the meeting should be attended by 3 people, but it was actually 3 people. The convening and convening of this meeting are in accordance with the relevant provisions of the Company Law of the People's Republic of China and other laws, regulations, rules, normative documents and the Articles of Association, and the resolutions formed by voting are legal and valid.

2. Deliberations of the Board of Supervisors

(1) Reviewed and approved the proposal on the remuneration plan of the company's supervisors in 2025

All supervisors of the company abstained from voting, and this proposal will be directly submitted to the general meeting of shareholders of the company for deliberation.

Voting result: 0 votes in favor; 0 votes against; abstentions: 0 votes; 3 abstentions.

(2) Reviewed and approved the proposal on the establishment of a special account for the company's raised funds

After deliberation, the board of supervisors believes that the company's opening of a special account for raising funds is in line with the progress of the company's project of issuing shares to specific targets and the plan for the use of raised funds. It complies with the provisions of relevant laws and regulations, and is conducive to the management and use of raised funds.

The result of the vote: 3 votes in favor; 0 votes against; Abstained 0 votes.

The announcement is hereby made.

Shanghai Cathay Biotechnology Co., Ltd

Board of Supervisors

December 31, 2024

Follow Yicai Global on

star50stocks

Ticker Name

Percentage Change

Inclusion Date